The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles.

Artificial Cells, Nanomedicine, and Biotechnology
Xiu-Ying LiQingshan Li

Abstract

High grade-gliomas are highly invasive and prone to metastasis, leading to poor survival and prognosis. Currently, we urgently need a new treatment strategy to effectively inhibit glioma. In this study, artemether and paclitaxel were used as two agents for tumour suppression. Two functional materials were synthesised and modified on the surface of the micelle as targeting molecules. The addition of two functional materials confers the ability of the micelles to effectively cross the blood-brain barrier (BBB) and then target the glioma cells. Thus, this dual-targeted delivery system allows the drug to play a better role in inhibiting tumour invasion and vasculogenic mimicry (VM) channels. In this paper, the anticancer effects of dual-targeted artemether plus paclitaxel micelles on glioma U87 cells were studied in three aspects: (I) In vitro and in vivo targeting assessment, including the role of penetrating BBB and targeting glioma; (II) In vitro regulation of invasion-associated proteins; (III) Inhibition of VM channels formation and invasion in vitro; (IV) The study of pharmacodynamics in tumour-bearing mice. These results suggest that dual-targeted artemether plus paclitaxel micelle may provide a new strategy to treat glioma ...Continue Reading

References

Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A GieseM Westphal
Apr 22, 2014·Expert Review of Molecular Diagnostics·Fred H HochbergRobert S Carter
Jun 20, 2014·Nature Communications·Stacey WatkinsHarald Sontheimer
Mar 21, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·O van TellingenH E de Vries
Sep 30, 2015·Nature·Norimichi NomuraDavid Drew
Mar 31, 2016·Nature Cell Biology·Edward L LaGory, Amato J Giaccia
Apr 2, 2016·Science Advances·Rishi R LullaRintaro Hashizume
Jul 30, 2016·Nature Communications·C DepnerA Acker-Palmer
Mar 5, 2017·Advanced Drug Delivery Reviews·Alexandros Marios SofiasChristine Allen
Aug 29, 2017·Nature Cell Biology·Evangelos GiampazoliasStephen W G Tait
Sep 16, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Gonçalves-RibeiroD G Molleví
Feb 8, 2018·Acta Neuropathologica·Stefan LiebnerGabriela Constantin
Mar 10, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Rui-Jun JuWan-Liang Lu
Jul 14, 2018·Nature Reviews. Cancer·Hellyeh Hamidi, Johanna Ivaska
Jul 26, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Xin WangXue-Tao Li
May 14, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Jing-Jing LiuRui-Jun Ju
May 16, 2019·Chemical Society Reviews·Wei TangXiaoyuan Chen
Aug 7, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Le ZhangYanping Wang
Oct 5, 2019·Radiologic Clinics of North America·Camilo Jaimes, Tina Young Poussaint

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.